NOW 2016 | Gene Editing: Empowering a Cure for Cancer and Other Medical Breakthroughs
Brown Advisory
JUNE 23, 2016
Andrew Hack, chief financial officer at biotech startup Editas Medicine, said his firm plans to use CRISPR technology to perform precise genetic modification to treat a wide variety of human diseases. This communication and any accompanying documents are confidential and privileged. They are intended for the sole use of the addressee.
Let's personalize your content